$1.7 million for Rutgers anti-HIV drug research

NEW BRUNSWICK/PISCATAWAY, N.J. Monday, June 5, marked the 25-year anniversary of the discovery of AIDS, and Rutgers researchers have just received new funds to support their pursuit of new ways to combat the virus. Patrick J. Sinko, Parke-Davis Professor of Pharmaceutics and Drug Delivery at Rutgers' Ernest Mario School of Pharmacy, has received a highly selective National Institutes of Health (NIH) MERIT award for more than $1.7 million.

The funding will support up to a 10-year extension of Sinko's continuing research into nanotechnology-based, targeted drug delivery for the treatment of human immunodeficiency virus (HIV), the virus that causes AIDS. Sinko, chair of the department of pharmaceutics at Rutgers, The State University of New Jersey, and his team are working to develop drug delivery systems to treat HIV-infected cells, and to assist the delivery of potent anti-HIV drugs to areas of the body that are typically difficult to access, such as the brain.

A limited number of the NIH MERIT (Method to Extend Research in Time) awards are made to investigators who have demonstrated superior competence and outstanding productivity in their research and are likely to do so in the future. Fewer than 5 percent of NIH grantees receive these awards.

Sinko has just completed four years of research supported by a $1.1 million grant from the National Institute of Allergy and Infectious Disease of the NIH. The $1.7 million MERIT award will now extend support of his research for five years. The grant is also potentially renewable for another five years with additional funding.

"Receiving a MERIT award from the National Institutes of Health represents an extraordinary level of scientific recognition and a confirmation of the importance of this innovative research," said John Colaizzi, dean of the Ernest Mario School of Pharmacy.

Sinko's delivery systems use nanocarriers miniscule biological "capsules" whose size is measured in billiont

Contact: Joseph Blumberg
732-932-7084 x652
Rutgers, the State University of New Jersey

Page: 1 2

Related biology news :

1. US Department of Defense awards $1.6 million for implantable biochip research
2. Nottingham biosciences million pound injection
3. $9 million EPSCoR grant to foster integrated research
4. 20 Kentucky firms share $1.9 million from state to match federal SBIR-STTR awards
5. $125 million bioenergy initiative powered by Midwest ag industry, MSU research
6. UC Davis is partner in new $125 million federal bioenergy research center
7. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
8. The BBVA Foundation commits 2.4 million euros to research in Ecology and Conservation Biology
9. New $1.16 million study investigates how dietary iron is used by cells
10. 5.9 million award gives UK aging research a new lease on life
11. NIH awards nearly $21 million to fund cutting-edge research equipment

Post Your Comments:

(Date:7/2/2020)... , ... July 01, 2020 , ... ... its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory ... 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a ... purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture ... facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... R&D, today announced that it has entered into a multi-year contract with ... to support their translational and clinical research strategy to discover and develop ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... ... August 29, 2020 , ... DuPont Nutrition ... in Wuxi, China. The new plant operation will provide the local animal production ... , “This facility will improve the flexibility of our offerings to the ...
(Date:8/15/2020)... ... August 13, 2020 , ... ... 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The ... economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, ...
(Date:8/12/2020)... (PRWEB) , ... August 11, ... ... a biopharmaceutical cold chain validation engineering firm, is making available for free ... the need to incorporate concurrent transport simulation testing into today’s biologics licensing ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly regarded ... on the purchase of greenfield for a new, expanded manufacturing facility. The site ... acres in the initial acquisition, with an option to purchase an additional 21 ...
Breaking Biology Technology:
Cached News: